Beijing Succeeder Technology Inc. (SHA:688338)

Market Cap	3.12B +16.5%
Revenue (ttm)	263.67M -13.8%
Net Income	87.14M -22.9%
EPS	0.84 -21.5%
Shares Out	103.97M
PE Ratio	35.70
Forward PE	n/a
Dividend	0.33 (1.12%)
Ex-Dividend Date	Jun 12, 2025

Volume	1,403,826
Average Volume	1,632,312
Open	29.96
Previous Close	29.45
Day's Range	29.51 - 30.32
52-Week Range	21.28 - 36.08
Beta	0.69
RSI	47.84
Earnings Date	Apr 24, 2026

About SHA:688338

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia, coronary heart disease, venous thromboembolism, and other thrombotic and bleeding disorders. Beijing Succeeder Technology...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 274
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688338

Financial Performance

In 2025, SHA:688338's revenue was 263.67 million, a decrease of -13.80% compared to the previous year's 305.87 million. Earnings were 87.14 million, a decrease of -22.88%.